Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Feizhou Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8218-5867; OpenAlex author ID A5101449794. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. The miR-1305/KLF5 negative regulatory loop affects pancreatic cancer cell proliferation and apoptosis. Co-author DOI 10.1007/s13577-025-01173-3↗
  2. RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration. Last author DOI 10.1002/jcp.27039↗
  3. High level of PTEN expression is associated with low-grade liver metastasis and satisfactory patient survival in pancreatic cancer. Co-author DOI 10.1016/j.arcmed.2011.10.008↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhichao Wang · 1 shared paper, 2025 · strength 0.28
  2. Changfa Wang · 1 shared paper, 2025 · strength 0.28
  3. Yufu Zhou · 1 shared paper, 2025 · strength 0.28
  4. Zhenglin Ou · 1 shared paper, 2019 · strength 0.10
  5. Zhen Luo · 1 shared paper, 2019 · strength 0.10
  6. Tong Han · 1 shared paper, 2019 · strength 0.10
  7. Wanpin Nie · 1 shared paper, 2011 · strength 0.03
  8. Chao Feng · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.